Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic (semaglutide) tablets 4 mg or 9 mg are prescription medicines used: along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes Ozempic injection is used: to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease Ozempic tablets are used: to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes who are at high risk for these events It is not known if Ozempic injection and Ozempic tablets are safe and effective for use in children

It's also approved to reduce the risk of major cardiovascular events (like heart attack or stroke) in adults with known heart disease and either obesity or overweight
All compounded formulations should remain refrigerated at 2-8C
De Filippis B, Valenti D, de Bari L, De Rasmo D, Musto M, Fabbri A, et al
Retatrutide & Pemvidutide are a triple agonist, which means they act on GLP-1R, GIP-R, & glucagon receptors (GCGR)
Furthermore, TAK1 activates mitogen-activated protein kinases and NF-B to trigger the production of proinflammatory cytokines 49